Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression.
Saved in:
| Title: | Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression. |
|---|---|
| Authors: | Patel VM; Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Cai Q; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Ahn R; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Hill K; Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, TX, USA., Wang J; Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. |
| Source: | Case reports in oncology [Case Rep Oncol] 2025 Nov 12; Vol. 19 (1), pp. 1-8. Date of Electronic Publication: 2025 Nov 12 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1662-6575 |
|---|---|
| DOI: | 10.1159/000549542 |
